x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934.
|
¨
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
Delaware
|
|
36-3688459
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
1001
Cambridge Drive, Elk Grove Village, Illinois
|
|
60007
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Class
|
|
Outstanding
at April 30, 2007
|
Common
Stock, par value $0.001 per share
|
|
190,600,000
|
|
1
|
|||
Item 1.
|
|
|
1
|
|
|
|
1
|
||
|
|
2
|
||
|
|
3
|
||
|
|
4
|
||
Item 2.
|
|
|
10
|
|
Item 3.
|
|
|
12
|
|
Item 4.
|
|
|
13
|
|
|
14
|
|||
Item 1.
|
|
|
14
|
|
Item 1A.
|
|
|
14
|
|
Item 5.
|
|
|
14
|
|
Item 6.
|
|
|
14
|
(Unaudited)
|
||||||
March
31,
|
December
31,
|
|||||
2007
|
2006
|
|||||
Assets:
|
|
|
|
|
|
|
Current
Assets:
|
||||||
Cash
and Equivalents
|
$
|
2,177,587
|
|
$
|
2,886,476
|
|
Inventory
|
6,299,186
|
6,368,599
|
||||
Accounts
Receivable, net
|
|
624,830
|
|
|
2,554,716
|
|
Prepaid
Expenses and Other
|
106,223
|
168,741
|
||||
Total
Current Assets
|
|
9,207,826
|
|
|
11,978,532
|
|
Property
and Equipment
|
|
1,353,960
|
|
|
1,334,203
|
|
Less:
Accumulated Depreciation
|
|
(846,545)
|
|
|
(811,167)
|
|
Net
Property and Equipment
|
|
507,415
|
|
|
523,036
|
|
Restricted
Certificates of Deposit
|
|
163,940
|
|
|
162,440
|
|
Goodwill
|
|
13,370,000
|
|
|
13,370,000
|
|
Intangible
assets, net
|
|
839,482
|
|
|
841,187
|
|
Total
Assets
|
$
|
24,088,663
|
|
$
|
26,875,195
|
|
Liabilities
and Stockholders' Equity:
|
||||||
Current
Liabilities:
|
|
|
|
|
|
|
Accounts
Payable
|
$
|
331,668
|
|
$
|
1,172,844
|
|
Inventory-related
material purchase accrual
|
|
78,091
|
|
|
328,663
|
|
Employee-related
accrued liability
|
153,593
|
284,653
|
||||
Accrued
professional services
|
|
76,000
|
|
|
93,000
|
|
Other
accrued liabilities and current deferred revenue
|
286,572
|
225,724
|
||||
Current
Portion of LT Debt, including related interest, with related
parties
|
|
11,489,852
|
|
|
11,295,957
|
|
Total
Current Liabilities
|
|
12,415,776
|
|
|
13,400,841
|
|
Deferred
facility reimbursement
|
98,750
|
102,500
|
||||
Deferred
revenue - non current
|
|
128,920
|
|
|
75,900
|
|
Notes
and related accrued interest with related parties
|
5,193,200
|
5,131,762
|
||||
Stockholders'
equity:
|
|
|
|
|
|
|
Preferred
stock; 300,000 shares authorized; No shares issued and outstanding
|
||||||
at March 31, 2007 and December 31, 2006
|
-
|
-
|
||||
Common
stock ($.001 par value); 250,000,000 shares authorized;
190,598,157
|
|
|
|
|
|
|
and 189,622,133 shares issued and outstanding at March 31, 2007
and
|
|
|
|
|
|
|
December 31, 2006, respectively
|
|
190,598
|
|
|
189,622
|
|
Additional
paid-in capital (net of unearned compensation)
|
172,864,096
|
172,379,842
|
||||
Accumulated
deficit
|
|
(166,802,677)
|
|
|
(164,405,272)
|
|
Total
Shareholders' Equity
|
6,252,017
|
8,164,192
|
||||
Total
Liabilities and Shareholders' Equity
|
$
|
24,088,663
|
|
$
|
26,875,195
|
|
Three
Months Ended
|
Three
Months Ended
|
||||||
March
31, 2007
|
March
31, 2006
|
||||||
Net
sales
|
$
|
953,248
|
$
|
1,325,589
|
|||
Costs
and expenses:
|
|
|
|
|
|
|
|
Cost
of sales
|
709,655
|
830,435
|
|||||
Research and development
|
|
|
621,055
|
|
|
463,524
|
|
Selling and marketing
|
583,244
|
630,905
|
|||||
General and administrative
|
|
|
1,199,647
|
|
|
940,648
|
|
|
|
|
|
|
|
|
|
Total
costs and expenses
|
|
|
3,113,601
|
|
|
2,865,512
|
|
Operating
loss
|
|
|
(2,160,353)
|
|
|
(1,539,923)
|
|
Other
income (Expense):
|
|||||||
Interest income
|
|
|
18,280
|
|
|
31,135
|
|
Interest expense
|
255,333
|
191,250
|
|||||
|
|
|
|
|
|
|
|
Total
other expense, net
|
(237,053)
|
(160,115)
|
|||||
|
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(2,397,406)
|
|
$
|
(1,700,038)
|
|
|
|
|
|
|
|
|
|
Basic
and diluted loss per share
|
$
|
(0.01)
|
$
|
(0.01)
|
|||
|
|
|
|
|
|
|
|
Weighted
average number of common shares outstanding
|
190,055,707
|
183,570,258
|
ISCO
INTERNATIONAL
|
|||||||
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|||||||
Three
Months Ended
|
Three
Months Ended
|
||||||
March
31, 2007
|
March
31, 2006
|
||||||
OPERATING
ACTIVITIES
|
|
|
|
|
|
|
|
Net
loss
|
$
|
(2,397,406)
|
$
|
(1,700,038)
|
|||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
46,995
|
|
|
32,580
|
|
Non-cash
compensation charges
|
|
|
485,228
|
|
|
220,931
|
|
Changes
in operating assets and liabilities
|
|
|
1,183,713
|
|
|
34,971
|
|
Net
cash used in operating activities
|
|
|
(681,470)
|
|
|
(1,411,556)
|
|
INVESTING
ACTIVITIES
|
|
|
|
|
|
|
|
Decrease/
(Increase) in restricted certificates of deposit
|
|
|
(1,500)
|
|
|
42,180
|
|
Payment
of patent costs
|
|
|
(11,412)
|
|
|
(7,124)
|
|
Acquisition
of property and equipment, net
|
|
|
(14,506)
|
|
|
(76,292)
|
|
Net
cash used in investing activities
|
|
|
(27,418)
|
|
|
(41,236)
|
|
FINANCING
ACTIVITIES
|
|
|
|
|
|
|
|
Exercise
of stock options
|
|
|
-
|
|
|
163,100
|
|
Net
cash provided by financing activities
|
|
|
-
|
|
|
163,100
|
|
|
|
|
|
|
|
|
|
(Decrease)/Increase
in cash and cash equivalents
|
|
|
(708,888)
|
|
|
(1,289,692)
|
|
Cash
and cash equivalents at beginning of period
|
|
|
2,886,476
|
|
|
3,486,430
|
|
Cash
and cash equivalents at end of period
|
|
$
|
2,177,588
|
|
$
|
2,196,738
|
|
March
31, 2007
|
December
31, 2006
|
||||||
Raw
materials
|
|
$
|
2,587,000
|
|
$
|
2,675,000
|
|
Work
in process
|
|
|
1,989,000
|
|
|
2,332,000
|
|
Finished
product
|
|
|
1,723,000
|
|
|
1,362,000
|
|
Total
|
|
$
|
6,299,000
|
|
$
|
6,369,000
|
|
Weighted
|
|||||
Average
Grant Date
|
|||||
Shares
|
Fair
Value (per share)
|
||||
Outstanding,
December 31, 2006
|
|
8,714,000
|
|
0.35
|
|
Granted
|
|
1,500,000
|
|
0.33
|
|
Forfeited
or canceled
|
|
(339,000)
|
|
0.38
|
|
Vested
|
|
(976,000)
|
|
0.37
|
|
Outstanding,
March 31, 2007
|
|
8,899,000
|
|
0.34
|
|
Payments
Due by Period
|
|||||||||||||||
Less
than 1
|
More
than
|
||||||||||||||
Year
|
Total
|
Year
|
1-3
Years
|
3-5
Years
|
5
Years
|
||||||||||
Long
Term Debt Obligations
|
$
|
17,787,000
|
|
$
|
11,749,000
|
|
|
-
|
|
$
|
6,038,000
|
|
|
-
|
|
Operating
Lease Obligations
|
$
|
1,609,000
|
|
$
|
202,000
|
|
$
|
414,000
|
|
$
|
429,000
|
|
$
|
564,000
|
|
Total
|
$
|
19,396,000
|
|
$
|
11,951,000
|
|
$
|
414,000
|
|
$
|
6,467,000
|
|
$
|
564,000
|
|
|
(a)
|
An
evaluation was performed under the supervision and with the participation
of the Company’s management, including its Chief Executive Officer, or
CEO, and Chief Financial Officer, or CFO, of the effectiveness of
the
Company’s disclosure controls and procedures, as such term is defined
under Rule 13a-15(e) promulgated under the Securities Exchange Act
of
1934, as amended (the “Exchange Act”) as of March 31, 2007. Based on
that evaluation, the Company’s management, including the CEO and CFO,
concluded that the Company’s disclosure controls and procedures are
effective to ensure that information required to be disclosed by
the
Company in reports that it files or submits under the Exchange Act,
is
recorded, processed, summarized and reported as specified in Securities
and Exchange Commission rules and
forms.
|
|
(b)
|
There
were no significant changes in the Company’s internal control over
financial reporting identified in connection with the evaluation
of such
controls that occurred during the Company’s most recent fiscal quarter
that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial
reporting.
|
ISCO
International, Inc.
|
||
By:
|
|
/s/
John Thode
|
|
Mr.
John Thode
|
|
|
President
and Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
By:
|
|
/s/
Frank Cesario
|
|
Frank
Cesario
|
|
|
Chief
Financial Officer
|
|
|
(Principal
Financial and Accounting Officer)
|
Exhibit
Number
|
|
Description
of Exhibit
|
31.1
|
|
Certification
by Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a),
as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
31.2
|
|
Certification
by Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a),
as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
32.1
|
|
Certification
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002
|